Question

In most hospitals, newborn babies are screened for a variety of metabolic disorders, including medium-chain acyl-CoA dehydrogenase deficiency (MCADD). This screening process uses high-performance liquid chromatography (HPLC) to determine the acylcarnitine profile in the bloodstream. In newborns with MCADD, which acylcarnitine is elevated?

Answer 1

Answer:

The acylcarnitine that is elevated in newborns with MCADD is C10.

Explanation:

MCADD (medium-chain acyl-CoA dehydrogenase deficiency) is a rare genetic disease that is given by a poor breaking of fat molecules, which leads to less energy and a build-up of substances that can be harmful to one's body.

A baby with MCADD often feels drowsy and sleepy, vomits and has seizures.

Kids with this disorder have to eat frequently and take special high sugar drinks.